Treatment of longstanding active giant cell arteritis with infliximab: Report of four cases

This publication has 10 references indexed in Scilit:

• Association of giant cell arteritis and polymyalgia rheumatica with different tumor necrosis factor microsatellite polymorphisms
  Arthritis & Rheumatism, 2000
• Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab
  Arthritis & Rheumatism, 2000
• Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor α (infliximab) in spondyloarthropathy: an open pilot study
  Annals of the Rheumatic Diseases, 2000
• Infliximab (chimeric anti-tumour necrosis factor α monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial
  The Lancet, 1999
• Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor ? monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis
  Arthritis & Rheumatism, 1998
• Adverse outcomes of antiinflammatory therapy among patients with polymyalgia rheumatica
  Arthritis & Rheumatism, 1997
• Polymyalgia rheumatica
  The Lancet, 1997
• GIANT CELL ARTERITIS AND POLYMYALGIA RHEUMATICA
  Medical Clinics of North America, 1997
• Tissue Cytokine Patterns in Patients with Polymyalgia Rheumatica and Giant Cell Arteritis
  Annals of Internal Medicine, 1994
• The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
  Arthritis & Rheumatism, 1990